Why Australia

Australia provides a safe, stable and straightforward environment in which to undertake your clinical development program:

  • Advantageous regulatory environment (no IND required).
  • Short start-up timelines due to seamless central ethics approval process. (WEBSITE)
  • Quick, inexpensive and efficient regulatory notification scheme. (CTN) (WEBSITE)
  • Standard Medicines Australia Clinical Trial Agreement templates. (WEBSITE)
  • Mature and robust healthcare system.
  • Access to R&D tax credit scheme. (WEBSITE)
  • Experienced global standard clinical researchers.
  • Access to world-class neuroscience practitioners.
  • Motivated patient populations.